Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Sotac Pharmaceuticals Limited (NSE: SOTAC), ISIN INE0O2D01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SOTAC last traded at ₹90.05, with a 52-week range of ₹95.10 to ₹139.65 (as of 20 Aug 2026).
Shareholding as of Mar 2026: promoters 72.85%, FIIs 16.79%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 68/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.